Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 27, 2022

SELL
$57.72 - $65.01 $3.53 Million - $3.97 Million
-61,095 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$57.92 - $72.58 $3.54 Million - $4.43 Million
61,095 New
61,095 $3.63 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sante Capital Fund, LP Portfolio

Follow Sante Capital Fund, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sante Capital Fund, LP, based on Form 13F filings with the SEC.

News

Stay updated on Sante Capital Fund, LP with notifications on news.